Discovery of novel modulators of metabotropic glutamate receptor subtype-5

Bioorganic and Medicinal Chemistry

Volumn 12, Issue 1, 2004, Pages 17-21

  Wang, Bowei ^a   Vernier, Jean Michel ^a   Rao, Sara ^a   Chung, Janice ^a   Anderson, Jeffery J ^a   Brodkin, Jesse D ^a   Jiang, Xiaohui ^a   Gardner, Michael F ^a   Yang, Xiaoqing ^a   Munoz, Benito ^a  

^a MERCK RESEARCH LABORATORIES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2 (3 METHOXY 4 PYRIDIN 2 YLPHENYL) 1,3 BENZOXAZOLE; 2 (3 METHOXY 4 PYRIDIN 2 YLPHENYL)IMIDAZO[1,2 A]PYRIDINE; 2 (3 METHOXY 4 PYRIDIN 3 YLPHENYL) 1,3 BENZOXAZOLE; 2 [4 (1,3 BENZOXAZOL 2 YL) 2 METHOXYPHENYL]ACETONITRILE; 6 (3 METHOXY 4 PYRIDIN 2 YLPHENYL) 2,3 DIHYDROIMIDAZO[2,1 B][1,3]THIAZOLE; 6 (3 METHOXY 4 PYRIDIN 2 YLPHENYL)IMIDAZO[1,2 B][1,3]THIAZOLE; ACETONITRILE; BENZOXAZOLE DERIVATIVE; IMIDAZOLE DERIVATIVE; IMIDAZOTHIAZOLE; METABOTROPIC RECEPTOR 5; METABOTROPIC RECEPTOR ANTAGONIST; PYRIDINE DERIVATIVE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DRUG POTENCY; DRUG SCREENING; DRUG SELECTIVITY; DRUG STRUCTURE; DRUG SYNTHESIS; IN VITRO STUDY; IN VIVO STUDY; NONHUMAN; RAT;

EID: 0347301871     PISSN: 09680896     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bmc.2003.10.021     Document Type: Article

References (19)

1. Spooren W.P.J.M., Gasparini F., Salt T.E., Kuhn R. Trends Pharmacol. Sci. 22:2001;331.
2. Walker K., Bowes M., Panesar M., Davis A., Gentry C., Kesingland A., Gasparini F., Spooren W.P.J.M., Stoehr N., Pagano A., Flor P.I., Varanesic I., Lingenhoehl K., Johnson E.C., Varney M., Urban L., Kuhn R. Neuropharmacology. 40:2001;1.
3. Bordi F., Ugolini A. Brain Res. 871:2001;223.
4. Walker K., Reeve A., Bowes M., Winter J., Wotherspoon G., Davis A., Schmid P., Gasparini F., Kuhn R., Urban L. Neuropharmacology. 40:2001;10.
5. Bhave G., Karim F., Carlton S.M., Gereau R.W. Nat. Neurosci. 4:2001;417.
6. Dogrul A., Ossipov M.H., Lai J., Malan T.P. Jr., Porreca P. Neurosci. Lett. 292:2000;115.
7. Cosford N.D., Tehrani L., Roppe J., Schweiger E., Smith N.D., Anderson J.J., Bristow L., Brodkin J., Jiang X., McDonald I., Rao S., Washburn M., Varney M.A. J. Med. Chem. 46:2003;204.
8. Ohnuma T., Augood S.J., Arai H., McKenna P.J., Emson P.C. Mol. Brain. Res. 56:1998;207.
9. Spooren W.P.J.M., Gasparini F., Bergmann R., Kuhn R. Europ. J. Pharmacol. 406:2000;403.
10. Awad H., Hubert G.W., Smith Y., Levey A.I., Conn P.I. J. Neurosci. 20:2000;7871.
11. Riedel G., Casabona G., Platt B., Macphail E.M., Nicoletti F. Neuropharmacology. 39:2000;1943.
12. Chapman A.G., Nanan K., Williams M., Meldrum B.S. Neuropharmacology. 39:2000;1567.
13. Chapman A.G., Nanan K., Williams M., Meldrum B.S. Neuropharmacology. 39:2000;1567.
14. Bruno V., Ksiazek I., Battaglia G., Lukic S., Leonhardt T., Sauer D., Gasparini F., Kuhn R., Nicoletti F., Flor P.I. Neuropharmacology. 39:2000;2223.
15. Chiamulera C., Epping-Jordan M.P., Zocchi A., Marcon C., Cottiny C., Tacconi S., Corsi M., Orzi F. Conquet. Nat. Neurosci. 4:2001;873.
16. Cho C.S., Kim D.T., Zhang J.Q., Ho S.-L., Kim T.-J., Shim S.C. J. Heterocycl. Chem. 39:2002;421.
17. Cosford N.D., Roppe J., Tehrani L., Schweiger E.J., Seiders T.J., Chaudary A., Rao S., Varney M. A. Bioorg. Med. Chem. Lett. 13:2003;351.
18. Anderson J.J., Bradbury M.J., Giracello D.R., Chapman D.F., Holtz G., Roppe J., King C., Cosford N.D., Varney M.A. Eur. J. Pharmacol. 473:2003;34.
19. Brodkin J., Busse C., Sukoff S.J., Varney M.A. Pharmacol. Biochem. Behavior. 73:2002;359.